Study Enrollment

Your details will not be published or shared.

Clinical Trial

A011401; Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

This study is being done to see if losing weight may help prevent breast cancer from coming back (recurring). Previous studies have found that women who are overweight or obese when their breast cancer is found (diagnosed) have a greater risk of their breast cancer recurring, as compared to women who were thinner when their cancer was diagnosed. At this time we do not know whether or not losing weight will reduce the risk of breast cancer returning. This study seeks to determine whether or not the higher risk for breast cancer recurrence in women who are overweight or obese when they are diagnosed with breast cancer could be reduced or eliminated if weight is lost. It is important to note that we do not know how much weight would need to be lost to lower the risk of breast cancer recurrence, or whether this strategy would work for all women. This study will help to show us whether weight loss programs should be a part of breast cancer treatment. For more detailed information please visit:

Eligibility Criteria

  • - Diagnosis of Breast Cancer within 12 months - No previous diagnosis of Breast Cancer within 5 years - Age 18 years or older - ECOG Performance status of 0 or 1 - May not have diabetes treated with insulin

Contact Information

    Sandy Wall, RN

    (706) 721-4430